Sign in

Kevin J. Fowler

@gratefull080504.bsky.social
381 followers 276 following 101 posts

Consultant, The Voice of the Patient;COIs: Alexion, Bayer, Biogen, Dimerix, eGenesis, Enyo, Maze Therapeutics MediBeacon, Memo Therapeutics, Phreesia, ProKidney, Purespring Therapeutics , Travere www.linkedin.com/in/kevinjohnfowler

PostsRepliesMedia
Kevin J. Fowler @gratefull080504.bsky.social · 07/02/2026
Thank you very much Suzie!
010
Kevin J. Fowler @gratefull080504.bsky.social · 17/08/2025
Thank you very much.
000
Kevin J. Fowler @gratefull080504.bsky.social · 15/05/2025
Thank you Eric for taking the time to read the article. As I point out in the article, it is time for the transplant community to acknowledge we need to move towards improving QOL and participation in life. Survival is not enough. You understand the issue completely with home dialysis.
010
Kevin J. Fowler @gratefull080504.bsky.social · 15/05/2025
Happy to have a discussion on the subject with you. I firmly believe QOL + participation in life is where the community should prioritize.
010
Kevin J. Fowler @gratefull080504.bsky.social · 15/05/2025
I completely agree with your statement. I think the implementation of PROMs allow patients to be heard. Speaking for myself, I have often felt unheard. When patients felt heard, I think the process becomes easier for both parties.
010
Kevin J. Fowler @gratefull080504.bsky.social · 15/05/2025
Thank you very much for reading the article.
100
Kevin J. Fowler @gratefull080504.bsky.social · 15/05/2025
I would like to thank Maarten Naesens, MD for the opportunity to write my position statement on where the field of transplantation needs to shift to. Now is the time to improve quality and participation of life after transplant. bit.ly/4jQToAP #openaccess
bit.ly
Frontiers Publishing Partnerships | Life After Kidney Transplantation: The Time for a New Narrative
The first successful kidney transplant in December 1954 between the Herrick brothers ushered in a new field of medicine. Over the almost seventy years, tho...
4113
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Sad but true. #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Thanks for allowing me to part of the conversation. My final thoughts: This research underscores that AMR is a continuum and the leading cause of graft failure. There is a critical need to understand AMR + develop preventive strategies and treatments so that grafts are not lost. #nephjc
150
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Agreed, and the further phenotyping will help lead to treatments for AMR. Kidney transplant physicians need more tools to preserve kidney transplants. The SONG initiative showed that kidney transplant recipients feared going on dialysis more than dying #nephjc
131
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
and resarch that will lead to treatments that are FDA approved. #nephjc
040
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
FSGS is now viewed as a continuum. I think rejection is moving in that direction as well. It is a mult-factorial issue that needs to be address in a similar manner. #nephjc
040
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Yes. #nephjc
010
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Good question that I hope is answered with future research. #nephjc
030
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Exactly. It is beginning to occur with IgAN + it is really need in kidney transplantation. #nephjc
040
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I will add another hopeful thought. Some of the medications approved for DKD are now being studied in kidney transplantation. They have anti-inflammatory properties that may dampen the inflammatory cascade. #nephjc
131
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
There is no consensus. Some programs do DSA testing for high risk patients, some for cause, and some annually. I believe the lack of FDA approved treatments has result in a lack of consensus. #nephjc
010
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
A very important kidney transplant precision study. Understand the various phenotypes + deliver targeted effective treatments #nephjc
120
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I wish surveillance DSA testing was done more often. It doesn't identify all of the problems but it is a good start. #nephjc
150
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
U of Wisconsin represented the US for adult recipients. Pediatric recipients were included as well. #nephjc
030
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
It is my theory that it does. #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I have seen many friends lose their kidney transplants prematurely. None of the current treatments in the US are FDA approved. Moreover, generally peaking recipients don't receive AMR education. #nephjc
051
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
Speaking from professional experience surveillance DSA testing is not done routinely. I now have a annual DSA test surveillance test #nephjc
140
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I will add this for discussion. The role of inflammation is very important. I work out routinely on my Elliptical since my transplant. I wish there were studies about the role of reducing inflammation + whether that may reduce the inflammation process #Nephjc
132
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I am a fan of understanding it so that treatments can be found for AMR #nephjc
260
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I have. Very important work to help strategy populations at risk + to develop AMR treatments #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
I admire your commitment!! #nephjc
110
Kevin J. Fowler @gratefull080504.bsky.social · 30/04/2025
#nephjc COI Biogen Worked in kidney transplant since 2017. Consulted for CSL Behring on AMR + now with Biogen KTX since August 2004
170
Kevin J. Fowler @gratefull080504.bsky.social · 03/04/2025
Malignant stupidity is a nice choice of words. I would add narcissistic stupidity as well.
020
Kevin J. Fowler @gratefull080504.bsky.social · 03/04/2025
I remember it well.
010
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
You are most welcome #nephjc
000
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
You are welcome @hswapnil.medsky.social ! #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
Need to depart. Take care everyone. If you ever have questions regarding #adpkd, contact me any time. #nephjc
160
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
Much more aggressive + imposes a greater quality of life isssue for women too. #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
In addition the patients have seen relatives on dialysis. That is a very strong motivator. #nephjc
031
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
The quality of life issues with tolvaptan create a significant burden for the user. There is a deep need for additional treatments #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
Thank you. #nephjc
010
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
I believe ADPKD has a high pre-emptive kidney transplant %. #nephjc
140
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
I am curious why SGLT2i are not recommended? What is the risk? I believe there is trial in France with SGLT2is in ADPKD. #nephjc
120
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
The pain was a real issue before kidney transplant + has continued post kidney transplant. It is difficult to predict its occurrence #nephjc
011
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
That was the direction that I was provided + and I was able to achieve the BP targets. #nephjc
010
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
I think our experience is very common. As with many kidney diseases, the knowledge still remains quite limited. #nephjc
020
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
I don't know. #nephjc
100
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
Genetic testing has to be thought through because of some negative consequences such as insurance policy denial #nephjc
121
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
There can be difference in families. I had PKD1 + my sister has PKD2. I went into kidney failure at 43 + she is 60 with native kidneys #nephjc
161
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
Another stumbling block was the lack of surrogate endpoint. TKV helped to move the field thanks to Mayo and Dr. Torres #nephjc
150
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
@gratefull080504.bsky.social No COI related to #ADPKD Several generations of our family have been impacted by #adpkd including me #nephjc
222
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
Tolvaptan was approved on April 24, 2018, not 2012 #nephjc
130
Kevin J. Fowler @gratefull080504.bsky.social · 26/03/2025
I will see you tonight #nephjc #adpkd
030
Kevin J. Fowler @gratefull080504.bsky.social · 18/03/2025
Like Tracy Morgan, I am a kidney transplant recipient and I had a poisoning a year ago. I almost died. Food poisoning is serious issue for kidney transplant recipients. I hope his kidney is doing well after experiencing vomiting.
020